1. Home
  2. HYPR vs APLT Comparison

HYPR vs APLT Comparison

Compare HYPR & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HYPR
  • APLT
  • Stock Information
  • Founded
  • HYPR 2014
  • APLT 2016
  • Country
  • HYPR United States
  • APLT United States
  • Employees
  • HYPR N/A
  • APLT 36
  • Industry
  • HYPR Medical Specialities
  • APLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • HYPR Health Care
  • APLT Health Care
  • Exchange
  • HYPR Nasdaq
  • APLT Nasdaq
  • Market Cap
  • HYPR 55.9M
  • APLT 69.0M
  • IPO Year
  • HYPR N/A
  • APLT 2019
  • Fundamental
  • Price
  • HYPR $1.39
  • APLT $0.48
  • Analyst Decision
  • HYPR Strong Buy
  • APLT Buy
  • Analyst Count
  • HYPR 3
  • APLT 6
  • Target Price
  • HYPR $1.28
  • APLT $6.10
  • AVG Volume (30 Days)
  • HYPR 482.9K
  • APLT 928.7K
  • Earning Date
  • HYPR 08-13-2025
  • APLT 08-13-2025
  • Dividend Yield
  • HYPR N/A
  • APLT N/A
  • EPS Growth
  • HYPR N/A
  • APLT N/A
  • EPS
  • HYPR N/A
  • APLT N/A
  • Revenue
  • HYPR $10,797,000.00
  • APLT $121,000.00
  • Revenue This Year
  • HYPR $12.31
  • APLT $415.60
  • Revenue Next Year
  • HYPR $29.29
  • APLT $1,323.96
  • P/E Ratio
  • HYPR N/A
  • APLT N/A
  • Revenue Growth
  • HYPR N/A
  • APLT N/A
  • 52 Week Low
  • HYPR $0.53
  • APLT $0.30
  • 52 Week High
  • HYPR $1.90
  • APLT $10.62
  • Technical
  • Relative Strength Index (RSI)
  • HYPR 67.19
  • APLT 57.77
  • Support Level
  • HYPR $1.17
  • APLT $0.42
  • Resistance Level
  • HYPR $1.55
  • APLT $0.46
  • Average True Range (ATR)
  • HYPR 0.12
  • APLT 0.04
  • MACD
  • HYPR 0.02
  • APLT -0.00
  • Stochastic Oscillator
  • HYPR 70.91
  • APLT 71.65

About HYPR Hyperfine Inc.

Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Share on Social Networks: